SCHEMBL4619174

SCHEMBL4619174

NC(=O)COCCOCCN1C(=O)C=CC1=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 7/20 0.69
FAAH O00519 3/20 0.41
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
HSP90AA1 P07900 2/20 0.39
TLR9 Q9NR96 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
XBP1 P17861 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GPR35 Q9HC97 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39
PTGS1 P23219 7/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21569738 0.86 MGLL (0.69) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL31171033 0.86 MGLL (0.69) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL24164310 0.86 MGLL (0.69) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL22708691 0.84 MGLL (0.66) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL19272736 0.84 MGLL (0.71) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL3206169 0.84 MGLL (0.71) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL15082420 0.83 MGLL (1.00) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL9643398 0.83 MGLL (1.00) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL140275 0.83 MGLL (1.00) MGLLFAAHALDH1A1HPGDHSP90AA1
SCHEMBL349749 0.83 MGLL (1.00) MGLLFAAHALDH1A1HPGDHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1889639-A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents ConjuChem Biotechnologies Inc. (CA) 2008-02-20 EP disclosed
EP-1212120-A2 METHODS AND COMPOSITIONS CONTAINING SUCCINIMIDE OR MALEIMIDE DERIVATIVES OF ANTINEOPLASTIC AGENTS, FOR PRODUCING LONG LASTING ANTINEOPLASTIC AGENTS Conjuchem, Inc. (CA) 2002-06-12 EP disclosed
WO-2001017614-A2 METHODS AND COMPOSITIONS CONTAINING SUCCINIMIDE OR MALEIMIDE DERIVATIVES OF ANTINEOPLASTIC AGENTS CONJUCHEM, INC. (CA) 2001-03-15 WO disclosed